Azurity Pharmaceuticals has sued Massachusetts drug company Bionpharma, claiming that its generic of Azurity’s Epaned product infringes on a brand new patent.
Apple has secured the backing of a major pharmaceutical industry trade association, as it seeks to persuade the US Court of Appeals for the Federal Circuit to revisit a case centring on a pair of health sensor patents.
AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga.
A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology.
Molina Healthcare claims that Jazz Pharmaceuticals delayed generics of its flagship narcolepsy drug Xyrem and hiked the drug prices to increase profits when it was on the verge of bankruptcy.
Medical device company, Globus Medical, has filed a lawsuit against competitor Life Spine, alleging infringement of seven different patents related to spinal tech implant technology.
Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents.
Teva Pharmaceuticals has once again petitioned the US Court of Appeals for the Federal Circuit to reconsider its decision in a dispute over generic drug labelling which held that the drugmaker infringed GlaxoSmithKline’s Coreg heart drug.
The English High Court has found that a challenged claim of Bayer's targeted cancer drug sorafenib is invalid due to obviousness, in a win for Israeli pharmaceutical company Teva Pharmaceuticals.
The US Court of Appeals for the Federal Circuit has held that claims of a patent covering an artificial heart valve were erroneously held to be unpatentable by the US Patent Trial and Appeal Board, in a blow to a medical device company owned by Abbott Laboratories.